Season 5, Episode 5 - JHEP Live: the new nomenclature for SLD: a multidisciplinary evaluation and approach
In this episode, the discussants will examine the following questions, raised after a Journal of Hepatology’s nomenclature article:
- Is the introduction of metabolic risk factors (MRF) for the definition of MASLD justified?
- What are the main issues regarding the measurement and thresholds for MRFs?
- Is the introduction of the MetALD category clinically justified?
- Is it necessary to worry about MRFs in a patient drinking increased or excessive amounts of alcohol and if yes, how should these be accounted for in disease classification systems?
Faculty: Vlad Ratziu (Moderator), Giulio Marchesini (Faculty), Nancy Reau (Faculty), Roberto Vettor (Faculty)
Related article: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Related episodes: EASL Studio from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
ℹ The episode will be broadcasted live on this page.
